Zonisamide Accord 100 mg hard capsules Ireland - English - HPRA (Health Products Regulatory Authority)

zonisamide accord 100 mg hard capsules

actavis group ptc ehf - zonisamide - capsule, hard - 100 milligram(s) - other antiepileptics; zonisamide

ZONEGRAN- zonisamide capsule United States - English - NLM (National Library of Medicine)

zonegran- zonisamide capsule

concordia pharmaceuticals inc. - zonisamide (unii: 459384h98v) (zonisamide - unii:459384h98v) - zonisamide 25 mg - zonegran is indicated as adjunctive therapy in the treatment of partial seizures in adults with epilepsy. zonegran is contraindicated in patients who have demonstrated hypersensitivity to sulfonamides or zonisamide. the abuse and dependence potential of zonegran has not been evaluated in human studies (see warnings, cognitive/neuropsychiatric adverse events subsection). in a series of animal studies, zonisamide did not demonstrate abuse liability and dependence potential. monkeys did not self-administer zonisamide in a standard reinforcing paradigm. rats exposed to zonisamide did not exhibit signs of physical dependence of the cns-depressant type. rats did not generalize the effects of diazepam to zonisamide in a standard discrimination paradigm after training, suggesting that zonisamide does not have abuse potential of the benzodiazepine-cns depressant type.